We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
32.00 | 1.91% | 1,705.00 | 1,701.00 | 1,701.50 | 1,718.50 | 1,673.00 | 1,685.50 | 5,853,296 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.21 | 70.03B |
TIDMGSK
RNS Number : 6820P
GlaxoSmithKline PLC
11 October 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Ms V A Whyte ==== ====================================== ================================================= b) Position/status Company Secretary ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.2029 27 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Ms S Jackson ==== ====================================== ================================================= b) Position/status SVP, Global Communications & CEO Office ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.2029 4 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr I W Whyte ==== ====================================== ================================================= b) Position/status PCA of Mrs V A Whyte (Company Secretary) ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.2029 682 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mrs D Connor ==== ====================================== ================================================= b) Position/status PCA of Mr R G Connor (President, Global Vaccines)
==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 10 October 2019. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.2029 500 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2019-10-10 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== =================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHEFLFFKBFBFBZ
(END) Dow Jones Newswires
October 11, 2019 11:10 ET (15:10 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions